CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Terns Pharmaceuticals, Inc.

TERN
$4.59B
Mid Cap
NASDAQBiotechnology🇺🇸North America59 employees

Drugs in Pipeline

4

Phase 3 Programs

0

Upcoming Catalysts

0

Next Catalyst

None scheduled

Market Overview

Stock performance and key metrics

TERN News
Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

Drug Pipeline
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply